Home/Filings/4/0000950170-25-048487
4//SEC Filing

Bjorkquist Jeanette M 4

Accession 0000950170-25-048487

CIK 0001426800other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:05 PM ET

Size

9.8 KB

Accession

0000950170-25-048487

Insider Transaction Report

Form 4
Period: 2025-03-29
Bjorkquist Jeanette M
Principal Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-03-31$9.85/sh180$1,7734,617 total
  • Award

    Stock Option (right to buy)

    2025-03-29+1,9001,900 total
    Exercise: $10.62Exp: 2035-03-29Common Stock (1,900 underlying)
  • Award

    Common Stock

    2025-03-29+1,6554,797 total
Footnotes (4)
  • [F1]Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2026; March 29, 2027; March 29, 2028; and March 29, 2029.
  • [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
  • [F4]Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029.

Documents

1 file

Issuer

ASSEMBLY BIOSCIENCES, INC.

CIK 0001426800

Entity typeother

Related Parties

1
  • filerCIK 0001945064

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:05 PM ET
Size
9.8 KB